Noile-Immune Biotech Inc. (TYO:4893)
Japan · Delayed Price · Currency is JPY 148.00
0.00 (0.00%)
Aug 27, 2026, 2:33 PM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 6.42 billion as of August 26, 2026. Its market cap has decreased by -17.59% in one year.
Market Cap
6.42B
Enterprise Value
2.88B
Revenue
1.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
148.00
ChartMarket Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 6.42B, a decrease of -79.21%. That is a compound annual growth rate of -39.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 6.42B | 11.53% |
| Dec 30, 2025 | 5.76B | -21.76% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
| Jun 28, 2023 | 30.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 7.72B |
| BrightPath Biotherapeutics | 7.36B |
| MEDINET | 7.07B |
| ADR Biomedical Holdings | 6.81B |
| CellSource | 6.69B |
| Chiome Bioscience | 6.55B |
| Chordia Therapeutics | 6.34B |
| PRISM BioLab Co.,LTD | 6.28B |